Vicore Pharma names ex-GSK executive Rob Slack as chief scientific officer
PUBT · 1d ago
Share
Listen to the news
- Vicore Pharma appointed Rob Slack as chief scientific officer, effective immediately.
- Slack joins from GSK, where he was vice president and head of respiratory biology.
- He replaces Johan Raud, who will move to a senior adviser role through upcoming milestones.
- Slack will lead research strategy, including development of buloxibutid and the next-generation AT2 receptor agonist pipeline.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicore Pharma Holding AB published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved